Cargando…

Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer

BACKGROUND: Lung cancer has the highest fatality rate of all cancer types. To improve patients’ survival and life quality, it is therefore very important to screen for and detect it at an early stage. METHODS: A negative enrichment–fluorescence in situ hybridization (NE‐FISH) approach was used to de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yang, Tian, Xudong, Gao, Lei, Jiang, Xiaohong, Fu, Rao, Zhang, Tingting, Ren, Tianying, Hu, Ping, Wu, Yaping, Zhao, Peige, Yang, Dawei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639255/ https://www.ncbi.nlm.nih.gov/pubmed/31132233 http://dx.doi.org/10.1002/cam4.2286

Ejemplares similares

Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
por: Yang, Dawei, et al.
Publicado: (2020)

Clinical Utility of Circulating Tumor Cells in Patients With Esophageal Cancer
por: Li, Yang, et al.
Publicado: (2022)

Prognostic significance of tumor-associated macrophages polarization markers in lung cancer: a pooled analysis of 5105 patients
por: Yi, Bin, et al.
Publicado: (2023)

Serum CYR61 as a potential biomarker for the diagnosis of esophagogastric junction tumor
por: Chu, Ling-Yu, et al.
Publicado: (2021)

Circulating lncRNA DANCR as a potential auxillary biomarker for the diagnosis and prognostic prediction of colorectal cancer
por: Shen, Xianjuan, et al.
Publicado: (2020)

Application of circulating tumor cells scope technique on circulating tumor cell research
por: Yang, Dawei, et al.
Publicado: (2014)

The prognostic significance of circulating tumor cells in head and neck and non‐small‐cell lung cancer
por: Kulasinghe, Arutha, et al.
Publicado: (2018)

The clinical significance of circulating tumor cells and T lymphocyte subtypes in pancreatic cancer patients
por: Xing, Yasi, et al.
Publicado: (2022)

Impact of circulating tumor DNA in hepatocellular and pancreatic carcinomas
por: Dhayat, Sameer A., et al.
Publicado: (2020)

Magnetically driven microfluidics for isolation of circulating tumor cells
por: Luo, Laan, et al.
Publicado: (2020)

Prognostic significance of programmed cell death‐ligand 1 expression on circulating tumor cells in various cancers: A systematic review and meta‐analysis
por: Ouyang, Yushu, et al.
Publicado: (2021)

Spatial distribution characteristics of tumor marker CA724 reference values in China
por: Jing, Jing, et al.
Publicado: (2019)

Reassessment of alkaline phosphatase as serum tumor marker with high specificity in osteosarcoma
por: Kim, Seung Hyun, et al.
Publicado: (2017)

Post surgery circulating free tumor DNA is a predictive biomarker for relapse of lung cancer
por: Hu, Wenwei, et al.
Publicado: (2017)

Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases
por: Seeberg, Lars Thomas, et al.
Publicado: (2017)

Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
por: Shi, Ji‐Hua, et al.
Publicado: (2019)

Mismatch repair status between primary colorectal tumor and metastatic tumor, a retrospective consistent study
por: Wang, Zheng, et al.
Publicado: (2019)

Clinical significance of TM4SF1 as a tumor suppressor gene in gastric cancer
por: Peng, Xing‐Chun, et al.
Publicado: (2018)

High expression of LEF1 correlates with poor prognosis in solid tumors, but not blood tumors: a meta-analysis
por: Yang, Xiaoqi, et al.
Publicado: (2020)

Using Tumor-Informed Circulating Tumor DNA (ctDNA)-Based Testing for Patients with Anal Squamous Cell Carcinoma
por: Azzi, Georges, et al.
Publicado: (2022)

Combined measurement of circulating tumor cell counts and serum tumor marker levels enhances the screening efficiency for malignant versus benign pulmonary nodules
por: Ma, Guojun, et al.
Publicado: (2022)

Clinical significance and functional validation of PPA1 in various tumors
por: Luo, Dehong, et al.
Publicado: (2016)

Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate Cancer
por: Wang, Ruiliang, et al.
Publicado: (2023)

The Value of Circulating Tumor Cells and Tumor Markers Detection in Lung Cancer Diagnosis
por: Guo, Sumin, et al.
Publicado: (2023)

Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection
por: Gutteridge, Alice, et al.
Publicado: (2017)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
por: Dong, Huan, et al.
Publicado: (2019)

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer
por: Corradetti, Michael N., et al.
Publicado: (2019)

Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer
por: Tan, Weige, et al.
Publicado: (2019)

Epithelial‐mesenchymal transition may be involved in the immune evasion of circulating gastric tumor cells via downregulation of ULBP1
por: Hu, Baoguang, et al.
Publicado: (2020)

Association of dose escalation of octreotide long-acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
por: Al-Efraij, Khalid, et al.
Publicado: (2015)

Characterization of Tumor Cells Using a Medical Wire for Capturing Circulating Tumor Cells: A 3D Approach Based on Immunofluorescence and DNA FISH
por: Gallerani, Giulia, et al.
Publicado: (2017)

Circulating tumor cells: biology and clinical significance
por: Lin, Danfeng, et al.
Publicado: (2021)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results‐based study
por: Tao, Lianyuan, et al.
Publicado: (2019)

KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma
por: Liu, Yi, et al.
Publicado: (2020)

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Unsupervised detection of fragment length signatures of circulating tumor DNA using non-negative matrix factorization
por: Renaud, Gabriel, et al.
Publicado: (2022)

Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer
por: Wang, Jiasi, et al.
Publicado: (2020)

Significantly increased anti‐tumor activity of carcinoembryonic antigen‐specific chimeric antigen receptor T cells in combination with recombinant human IL‐12
por: Chi, Xiaowei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5cjt2m4oceognth4d91i723svf